OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Genomics
(7)
Transcriptomics
(2)
Organisms
Homo sapiens
(8)
Mus musculus
(1)
Repository
EGA
(6)
biostudies-arrayexpress
(3)
Technology Type
Illumina HiSeq 2000
(1)
Publication Date
2012
(2)
2013
(1)
Study type
Transcription profiling by array
(2)
ChIP-seq
(1)
Release Date
2013
(4)
2012
(4)
2021
(3)
2025
(2)
2017
(2)
2024
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Not available
S-EPMC3295550
|
biostudies-literature
Cite
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.
Not available
S-EPMC3577952
|
biostudies-literature
Cite
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.
Not available
S-EPMC3731981
|
biostudies-literature
Cite
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
Not available
S-EPMC8673586
|
biostudies-literature
Cite
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.
Not available
S-EPMC5562170
|
biostudies-literature
Cite
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study.
Not available
S-EPMC11803179
|
biostudies-literature
Cite
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
Not available
S-EPMC3518729
|
biostudies-literature
Cite
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
Not available
S-EPMC3595425
|
biostudies-literature
Cite
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score.
Not available
S-EPMC3918538
|
biostudies-literature
Cite
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
Not available
S-EPMC8288671
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
